AstraZeneca partners with VaxEquity in RNA deal
AstraZeneca PLC updates Sign up to myFT Daily Digest to be the first to know about AstraZeneca PLC news. AstraZeneca has agreed its first major deal in RNA, signing a partnership with VaxEquity to create therapeutics using the technology that first proved itself with Covid-19 vaccines. The UK drugmaker will commercialise up to 26 drug…
Read more